INS and Parkinson disease: Accumulating evidence suggests that similar dysregulation of glucose and energy metabolism seems to be an early event in the pathogenesis of sporadic PD, indicating that the insulin signaling pathway may potentially be a novel target for disease modification (Athauda and Foltynie, 2016).